ABSTRACT: The evidence for a genetic component in the aetiology of sarcoidosis includes familial aggregation, associations with genetic polymorphisms, and linkage to the major histocompatibility complex class region on chromosome 6p. Unfortunately, the majority of genetic associations with sarcoidosis have not been consistently replicated.
Sarcoidosis is a systemic granulomatous disease of unknown aetiology that can affect any organ system, but most frequently includes the lungs (in y90% of cases), skin and eyes. A genetic susceptibility to sarcoidosis has been supported by studies demonstrating familial clustering [1] and a higher prevalence of disease in first-degree relatives [2] . Clustering of cases within specific ethnic groups also suggests a genetic susceptibility. In the USA, African Americans have a higher disease incidence and morbidity compared with Caucasians [3] . The pathological hallmark of sarcoidosis is multinucleated noncaseating granulomas in affected organs. Granuloma burden is indicative of disease activity and longterm active disease can lead to fibrosis and organ dysfunction. Key genes that play a role in granuloma formation and persistence include angiotensin converting enzyme (ACE), tumour necrosis factor (TNF)-a, and the vitamin D receptor (VDR).
The epithelioid cells in sarcoid-granulomas secrete w40 different cytokines and other mediators, including ACE [4] . Epithelioid cells of sarcoid granulomas contain ACE, and ACE synthesis in monocyte cell culture can be modulated by T-lymphocytes obtained from sarcoid patients [5] . Serum ACE levels in healthy individuals [6] and sarcoidosis patients [7] are influenced by a 287 base pair Alu sequence either present (insertion (I)) or absent (deletion (D)) in intron 16 of the ACE gene. Association studies of the ACE I/D polymorphism and sarcoidosis have produced mixed results. The ACE D allele, which is associated with higher serum ACE levels [6] , has been found associated with increased sarcoidosis risk in African Americans [8] , Japanese women [7] and in sarcoid-affected family members from a German population [9] . Conversely, other studies in both Caucasians [10, 11] and Japanese [12] have failed to find an association between the ACE I/D polymorphism and sarcoidosis susceptibility or progression.
TNF-a is a cytokine that probably has a key role in granuloma formation [13] . TNF-a is increased at sites of disease activity [14] and anti-TNF-a agents have shown promising therapeutic value in chronic sarcoidosis [15] . At least eleven polymorphisms in the promoter region of the TNF-a gene have been reported [16] but of these a G to A single base pair (bp) transition at position -307 is considered the most likely to affect gene transcription [16] . Several studies have examined this polymorphism in relation to sarcoidosis susceptibility [17] [18] [19] , with a single case-control study in African Americans having null findings [20] .
The active form of vitamin D, 1,25-dihydroxyvitamin D 3 (1,25(OH) 2 D 3 ), a promoter of multinucleated giant cell formation [21] , is produced at sites of sarcoid granulomas [22] , and is elevated in sarcoidosis patients [23] . This hormone acts through the binding of intranuclear VDRs [24] and has been shown to interact directly with interferon gamma to promote the granulomatous process [25] . Several polymorphisms with potential functional significance have been identified in the VDR gene [26] . The Bsm I and Apa I polymorphisms are located in noncoding regions, whereas the Taq I polymorphism is in an exon but leads to a silent codon change with the nucleotides ATT and ATC both coding for isoleucine at codon 352. The b allele of the Bsm I polymorphism, which has a reported association with sarcoidosis susceptibility [27] , is in strong linkage disequilibrium with the absence of a Taq I cleavage site (T allele) in both Caucasians and African-Americans [28] . Another DNA sequence variant in the VDR gene is a thymine/cytosine (T/C) polymorphism in the first of two potential start (ATG) codons detected by restriction fragment length polymorphism using the endonuclease Fok I. The functional significance of the Fok I polymorphism is uncertain. However, most data indicate that the F allele, which lacks the first ATG start codon resulting in a transcribed protein three amino acids shorter than the variant f allele, is more effective in transactivation of the 1,25(OH) 2 D 3 signal [29] . One study has reported an association of the f allele with tuberculosis [30] .
Since conflicting case-control reports of sarcoidosis associations with variants in the ACE, VDR and TNF-a genes exist, the present authors attempted to replicate these associations in a family-based study of sarcoidosis in AfricanAmerican nuclear families. The strength of the family-based design is that it controls for genetic background unrelated to disease. While case-control samples are generally easier to collect and are statistically more powerful than family-based samples under some circumstances [31] , case-control samples can produce spurious associations because of ethnic admixture or other problems relating to inappropriate controls [32] . Therefore, the results presented here should help clarify the role of the ACE (I/D), VDR (TaqI and Fok I) and TNF-a (-307) genetic polymorphisms with regard to sarcoidosis risk in African Americans.
Methods

Study sample
The study protocol was approved by the Henry Ford Hospital Institutional Review Board. Diagnosis was confirmed by tissue biopsy in 86% of the index cases and in all cases with normal (stage 0) chest radiographs. The cases without histological confirmation had radiographical evidence of bilateral hilar adenopathy, a compatible clinical presentation and were observed for o2 yrs with no other medical condition that could explain the clinical course.
From a total of 623 eligible probands, 359 (58%) were enrolled with one or more first-degree family member(s). Of these, 234 had two or more parents or sibs that donated a blood sample. An additional 10 African-American sarcoidosis families were recruited outside the Henry Ford Health System, resulting in 244 total families. Both parents were genotyped when available. When one or both parents were unavailable for genotyping, all available full sibs were genotyped. Using a panel of unlinked markers, 20 families (8.2%) with Mendelian segregation inconsistencies and two families (0.8%), where the proband, after further follow-up, was not found to have sarcoidosis, were excluded from the analysis. Three of the remaining 222 families had two separate nuclear families, which were analysed separately, resulting in 225 nuclear families or a total of 704 individuals for study. The three basic family configurations are shown in table 1. While the majority of family members with a sarcoidosis history were probands through whom the family was ascertained, there were also 22 sibs and four additional family members (who were treated as index cases in the analysis) with a history of sarcoidosis based on self-report of a physician diagnosis of this condition. In 18 of the 22 sib cases, and the other four additional family member cases, the diagnosis was confirmed by biopsy. In the remaining four sib cases, a medical record review revealed a chest radiograph report of bilateral hilar adenopathy at the time of diagnosis. Most families (90%) had a single affected offspring and w80% of families had additional unaffected sibs.
Phenotyping
Using a previously described criteria used for organ system involvement [33] , affected sibs were phenotypically categorised under three broad categories: mild, moderate, or severe. Mild cases were asymptomatic or had normal organ systems without treatment, or spontaneously resolved to normal within 2 yrs of presentation. Moderate cases had a symptomatic disease course with minimal residual abnormality in any organ with or without treatment, or a disease course for w3 yrs with some residual abnormality despite therapy. Severe cases had progressive organ dysfunction for o3 yrs, despite therapy.
Genotyping
High molecular weight DNA was isolated from anticoagulated blood by detergent lysis and organic extraction. The diallelic ACE polymorphism was genotyped by enzymatic amplification of a segment within intron 16 with the 190 and 490 base pair alleles resolved by 6% polyacrylamide gel electrophoresis. The primers were designed as previously described [8] . Amplification was performed using 100 ng of genomic DNA and 10 picomol (pmol) of each primer at 94uC for 1 min, 58uC for 1 min and 72uC for 2 min, for 30 cycles. To confirm that genotypes with only a D band were true homozygotes rather than mistyped ID heterozygotes due to preferential amplification of the D allele, a second reaction was performed using the sense primer labelled with gamma [ 32 P] ATP. Alleles were separated by acrylamide gel electrophoresis, stained with ethidium bromide to display molecular weight markers and autoradiographed to detect alleles.
The VDR Taq I and Fok I polymorphisms were typed by amplification and restriction fragment length polymorphism as previously described [30] . Taq I identifies a silent T to C base change at nucleotide 352. Fok I identifies a C to T transition that creates an alternative initiation site three codons upstream from a second ATG start site. Alleles were separated by agarose gel electrophoresis, and detected with ethidium bromide. Each DNA sample was assayed at least twice per marker, to confirm genotype.
The G to A transition at position -307 of the TNF-a gene was determined by amplification of a 413 bp region incorporating two polymorphisms. Amplification was performed using the sense primer 59-TTCCTGCATCCTGTCTGGAA-39 and antisense primer, 59-AGGGAGCGTCTGA-TGGCTG-39 at 1 pmol per reaction, 2 mM deoxynucleotidetriphosphates, 10 ng DNA, and 0.62 unit Taq DNA polymerase (Promega, 
Statistical methodology
To determine whether one or more alleles at the locus of interest was associated with the sarcoidosis phenotype, a Family-Based Association Test (FBAT) statistic, S, calculated using the FBAT software was used [34] . In short, this test statistic determines whether a certain allele in a nuclear family is transmitted to affected offspring more (or less) often than would be expected under Mendelian segregation. Test statistics for both dominant and additive inheritance models were computed. The outcome for initial analyses was a dichotomous affection status variable. More in depth phenotype models were also examined in which the three phenotypic levels were treated as either a dichotomous or an ordinal variable. For the former parameterisation, a multivariate model was used where three 0, 1 dummy variables were coded corresponding to absence or presence of the phenotype in question. For the latter parameterisation, affected sibs were coded as 1, 2 or 3 with a higher number corresponding to a more severe phenotypic level. For both types of parameterisations, unaffected sibs were coded as zero.
The statistical power of the study sample for detecting an association between the putative risk allele of each polymorphism and sarcoidosis was calculated with the power calculation of Family-Based Test software [35] . Power calculations were conditional on the frequency of each risk allele, an estimated lifetime risk of 1% [3] , the study sample configuration depicted in table 1 and a range of genotype relative risks (cs). Using these parameters, expected genotypicspecific penetrance values, f 2 (two risk alleles), f 1 (one risk allele), and f 0 (no risk alleles), under additive (f 0= 2f 1 -f 2 ), multiplicative (f 0= f 1 2 /f 2 ) and dominant (f 1= f 2 ) inheritance models could be calculated. The routine used to compute power estimates for the family-based analysis was based on a second-order Taylor expansion, which has been shown to have good precision for samples sizes of o100 families [35] . Table 3 shows the biallelic association tests for the putative risk allele of each polymorphism. In table 3, both the observed and expected values of allelic transmissions, S and E(S), respectively, are based on the genetic model postulated. Computation of the variance of S, allowed estimation of a significance level for a large number of families based on a Z statistic, which is normally distributed with mean 0 and variance 1, and defined as:
Results
Multiallelic test
Under both dominant and additive models of inheritance, none of the four alleles markedly deviated from the null hypothesis. Since it is possible that the polymorphisms under study could be risk factors for disease progression rather than susceptibility, the outcome of disease phenotype was analysed next instead of affection status. Phenotype data were available for sibs in 163 of the 225 (72%) study families. Table 4 depicts four different types of analyses based on inheritance models (dominant and additive) and phenotypic parameterisations. While no statistically significant results were observed, the VDR Fok I polymorphism had a marginally significant result (p=0.08) under an additive model with a multivariate phenotype. For the dichotomous phenotypic outcome, no assumptions were made as to the relationship of one phenotypic category with another, as compared with the ordinal phenotypic outcome that was modelled such that increasingly severe phenotypic categories had higher covariate values. Among the phenotyped-affected sibs, the VDR Fok*f allele had an increasingly higher frequency by severity of phenotypic category, i.e. 33.8% in mild cases, 42.5% in moderate cases and 51.7% in severe cases. The frequency of the VDR Fok*f allele among the unaffected sibs in these families was 41.3%. Since the presented results were largely negative, the current authors next tested what statistical power the present study sampled afforded. Statistical power was calculated for the putative risk allele of each of the four polymorphisms under study. For each allele and inheritance model combination, genotype relative risks (c) ranging 1-5 were tested at the type I error (a) levels of 5 and 1% ( fig. 1 ). For the ACE I/D*D allele, cs of o3 were detected at the a=0.05 level with y80% statistical power under an additive inheritance model, and with 90% statistical power under a multiplicative inheritance model. At the a=0.01 level for the additive and multiplicative models, cs of o4 could be detected with o80% power depending on the inheritance model. Under a dominant inheritance model, the statistical power only approached 60% for a c value of 5 at a=0.05. For the VDR Fok I*f and Taq I*t alleles, cs of o3 were detected at the a=0.05 level with o90% statistical power under all three inheritance models tested. Likewise cs of o3 could be detected with o70% statistical power under all three inheritance models tested at the a=0.01 level. Statistical power for cs of o4 could be detected with y100% power under all three inheritance models tested at both a levels (0.01 and 0.05) tested. Statistical power estimates for the TNF-307*A allele were virtually identical to the two VDR alleles under the dominant and additive inheritance models and slightly less under the multiplicative inheritance model.
Discussion
Noncaseating granulomas are the histological hallmark of sarcoidosis, therefore, the present study investigated polymorphisms in candidate genes probably involved in granuloma formation and maintenance. Conflicting case-control study results with respect to sarcoidosis risk exist for polymorphisms in the ACE [7] [8] [9] [10] [11] [12] [36] [37] [38] [39] [40] , VDR [27, 41] , and TNF-a [17] [18] [19] [20] 42 ] genes (table 5) . Therefore, the current authors tested polymorphisms in these genes for associations with sarcoidosis in African-American families. Although the present study had sufficient statistical power to detect effect sizes of o3 under an additive inheritance model, no significant associations were found.
One possible reason for the inconsistent results across sarcoidosis genetic association studies could be case heterogeneity. Inclusion of misdiagnosed cases will bias results towards the null hypothesis, but an unrepresentative case group can either artificially increase or decrease an odds ratio. Many sarcoidosis studies rely on cases drawn from specialised clinics that treat more severe and advanced cases. If any of these polymorphisms are truly related to sarcoidosis progression or disease subtypes, as several studies report for the ACE [8, 36] and TNF-a [17, 42] polymorphisms, then a disproportionate mix of disease types among cases may bias an odds ratio measuring sarcoidosis susceptibility. In the present study population most cases were phenotyped, so the present authors were able to examine the relationship between the four polymorphisms under study and disease severity. No association was found between either the ACE I/D or TNF-307 polymorphisms and disease phenotype, which would suggest that neither of these polymorphisms are related to disease progression in African Americans and that the case mix in the present study population did not influence its susceptibility results. If the TNF-307 polymorphism is actually a marker for Lofgrens syndrome and erythema nodosum in sarcoidosis, as several studies report [17, 42] , then these conditions being rare in African-American sarcoidosis cases [43] may explain the negative findings with respect to this polymorphism in the current study. However, the extent to which the current authors could exclude a disease progression gene was limited by a smaller sample size due to missing and incomplete phenotype data, which did not allow the present study to consider the full range of phenotypic expressions the genes under study could exhibit.
Genetic and environmental background can also affect case-control genetic association results. All four polymorphisms that were studied are observed in Caucasian, Japanese and African-American populations but their effect on disease susceptibility may be altered by other genetic or environmental factors. If these factors vary among ethnic groups, then ethnic-specific associations of a given polymorphism with sarcoidosis susceptibility are possible.
In the study by NIIMI et al. [27] , the Bsm I B allele was overrepresented in sarcoidosis patients but GULEVA and SEITZER [41] subsequently reported a failure to replicate this finding in a German Caucasian population. In the current study population, the corresponding t allele for the Taq I polymorphism showed no preferential transmission to affected offspring. The current study also examined the Fok I VDR polymorphism, which is in linkage equilibrium with the Taq I/Bsm I allele group [30] , and found that this polymorphism was not associated with sarcoidosis susceptibility but the variant f allele may have a modest association with chronic sarcoidosis. The potential functional relevance of the Fok I polymorphism [29] and the association of VDR genotypes with other granulomatous disorders [44, 45] would suggest that the VDR gene warrants further investigation in sarcoidosis. However, in terms of sarcoidosis susceptibility both VDR alleles tested in the present study had an 80% power to detect a 2-fold increased risk under a dominant model, which is the risk level for the heterozygote VDR Bsm I polymorphism previously reported [27] .
The extent to which population stratification biases results of case-control genetic association studies is a debated topic. While in theory, selection of a control sample from the same population that cases are drawn should avoid population stratification, in practice uniform case/control sampling is difficult to achieve. Statistical methods to adjust for population stratification using population-specific alleles have been proposed [46] but these methods have yet to be applied widely and may be prone to overcorrection of potential biases. The family-based study design used in the present study provides a sampling procedure that avoids the potential bias of case-control sampling without making any elaborate statistical corrections.
In summary, the present study found no evidence for an association between sarcoidosis susceptibility in African Americans and three key genes, angiotensin converting enzyme, vitamin D receptor and tumour necrosis factor-a, involved in granuloma formation. Overall results from past case-control studies of polymorphisms in these genes are equivocal with regard to sarcoidosis susceptibility. The results of the present study should not be subject to population stratification since potential confounding by genetic background was controlled in the study design. The current study was also sufficiently powered to detect levels of association with disease susceptibility that have been previously reported. The presented results suggest that genetic control of the granulomatous reaction is not related to sarcoidosis susceptibility in African Americans. Alternatively, the angiotensin converting enzyme, vitamin D receptor and tumour necrosis factor-a genes may not be optimal candidates for studying the sarcoidosis granulomatous reaction in relation to disease susceptibility in African Americans. 
